Liu et al. reported that FGF5 secreted by CAFs activated FGFR2 in NPC cells, which in turn upregulated the Keap1–Nrf2–HO-1 pathway and blocked cisplatin-induced ferroptosis [30]. The gene discussed is FGFR2; the disease is nasopharyngeal carcinoma.